Abstract
The KCa3.1 inhibition up-regulates IL-10 expression in regulatory T (Treg) cells in the recovery phase of inflammatory bowel disease (IBD) model mice; however, the underlying signaling pathway remains unclear. We investigated the involvement of AP-1 (Fos/Jun) and NF-κB in the expression of IL-10 and its transcription factors (TFs) in in vitro-induced mouse splenic Treg cells. The pharmacological inhibition of JNK reversed KCa3.1 inhibition-induced increases in the expression of IL-10 and its TFs. The inhibition of KCa3.1 increased phosphorylated JNK and c-Jun levels. Therefore, the JNK/c-Jun signaling pathway may contribute to the KCa3.1 inhibition-induced up-regulation of IL-10 in peripherally-induced Treg cells.
Keywords:
IL-10; JNK/c-Jun; K(Ca)3.1.
Copyright © 2021 The Authors. Production and hosting by Elsevier B.V. All rights reserved.
MeSH terms
-
Animals
-
Disease Models, Animal
-
Gene Expression / genetics*
-
Inflammatory Bowel Diseases / genetics*
-
Interleukin-10 / genetics*
-
Interleukin-10 / metabolism*
-
Intermediate-Conductance Calcium-Activated Potassium Channels / antagonists & inhibitors*
-
Intermediate-Conductance Calcium-Activated Potassium Channels / physiology*
-
JNK Mitogen-Activated Protein Kinases / metabolism*
-
MAP Kinase Signaling System / genetics*
-
MAP Kinase Signaling System / physiology*
-
Mice
-
NF-kappa B / metabolism
-
Phosphorylation
-
Proto-Oncogene Proteins c-jun / metabolism*
-
T-Lymphocytes, Regulatory / metabolism*
-
Transcription Factor AP-1 / metabolism
-
Transcription Factors / genetics
-
Transcription Factors / metabolism
Substances
-
IL10 protein, mouse
-
Intermediate-Conductance Calcium-Activated Potassium Channels
-
Kcnn4 protein, mouse
-
NF-kappa B
-
Proto-Oncogene Proteins c-jun
-
Transcription Factor AP-1
-
Transcription Factors
-
Interleukin-10
-
JNK Mitogen-Activated Protein Kinases